<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Acta Neuropathol Commun</journal-id>
<journal-id journal-id-type="iso-abbrev">Acta Neuropathol Commun</journal-id>
<journal-title-group>
<journal-title>Acta Neuropathologica Communications</journal-title>
</journal-title-group>
<issn pub-type="epub">2051-5960</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31651360</article-id>
<article-id pub-id-type="pmc">6813971</article-id>
<article-id pub-id-type="publisher-id">812</article-id>
<article-id pub-id-type="doi">10.1186/s40478-019-0812-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Xiao</surname>
<given-names>Shangxi</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>McKeever</surname>
<given-names>Paul M.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lau</surname>
<given-names>Agnes</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Robertson</surname>
<given-names>Janice</given-names>
</name>
<address>
<phone>(416) 507-6878</phone>
<email>jan.robertson@utoronto.ca</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution>Tanz Centre for Research in Neurodegenerative Diseases, </institution><institution>University of Toronto, </institution></institution-wrap>Krembil Discovery Tower, 60 Leonard Ave., 4th floor - 4KD-481, Toronto, ON M5T 0S8 Canada </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution>Department of Laboratory Medicine and Pathobiology, </institution><institution>University of Toronto, </institution></institution-wrap>Toronto, ON Canada </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>24</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>24</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>7</volume>
<elocation-id>161</elocation-id>
<history>
<date date-type="received">
<day>2</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">A hexanucleotide repeat expansion in a noncoding region of <italic>C9orf72</italic> is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Reduction of select or total C9orf72 transcript and protein levels is observed in postmortem C9-ALS/FTD tissue, and loss of <italic>C9orf72</italic> orthologues in zebrafish and <italic>C. elegans</italic> results in motor deficits. However, how the reduction in C9orf72 in ALS and FTD might contribute to the disease process remains poorly understood. It has been shown that C9orf72 interacts and forms a complex with SMCR8 and WDR41, acting as a guanine exchange factor for Rab GTPases. Given the known synaptosomal compartmentalization of C9orf72-interacting Rab GTPases, we hypothesized that C9orf72 localization to synaptosomes would be required for the regulation of Rab GTPases and receptor trafficking. This study combined synaptosomal and post-synaptic density preparations together with a knockout-confirmed monoclonal antibody for C9orf72 to assess the localization and role of C9orf72 in the synaptosomes of mouse forebrains. Here, we found C9orf72 to be localized to both the pre- and post-synaptic compartment, as confirmed by both post-synaptic immunoprecipitation and immunofluorescence labelling. In C9orf72 knockout (C9-KO) mice, we demonstrated that pre-synaptic Rab3a, Rab5, and Rab11 protein levels remained stable compared with wild-type littermates (C9-WT). Strikingly, post-synaptic preparations from C9-KO mouse forebrains demonstrated a complete loss of Smcr8 protein levels, together with a significant downregulation of Rab39b and a concomitant upregulation of GluR1 compared with C9-WT mice. We confirmed the localization of Rab39b downregulation and GluR1 upregulation to the dorsal hippocampus of C9-KO mice by immunofluorescence. These results indicate that C9orf72 is essential for the regulation of post-synaptic receptor levels, and implicates loss of C9orf72 in contributing to synaptic dysfunction and related excitotoxicity in ALS and FTD.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Amyotrophic lateral sclerosis</kwd>
<kwd>Frontotemporal dementia</kwd>
<kwd>C9orf72</kwd>
<kwd>PSD-95</kwd>
<kwd>GluR1</kwd>
<kwd>Rab39b</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>ALS Canada-Brain Canada Arthur J. Hudson Translational Team Grant</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neurodegenerative disease primarily affecting motor neurons of the motor cortex, brain stem, and spinal cord. With no effective treatment, disease course is typically rapid, resulting in complete paralysis and death within 2–5 years after diagnosis. Hexanucleotide (G4C2) repeat expansions within the first intron of <italic>C9orf72</italic> are the most common known genetic cause of both ALS and frontotemporal dementia (FTD) [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Initial reports on <italic>C9orf72</italic> expansions indicated that a length of &gt; 30 was pathogenic; however, there have been several cases where 30–70 repeats do not result in disease, indicating there is no discernible pathological cut-off [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. As a result, how the expanded G4C2 repeats in <italic>C9orf72</italic> cause neurodegeneration in ALS and FTD remains largely uncertain. Three potential pathomechanisms have been proposed to result from the repeat expansions [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]: (1) RNA-mediated toxicity through sequestration of RNA-binding proteins in nuclear repeat RNA foci; (2) accumulation of five dipeptide repeat (DPR) proteins, glycine-alanine (GA), glycine-arginine (GR), proline-alanine (PA), proline-arginine (PR), and glycine-proline (GP), by repeat-associated non-ATG (RAN) translation; and (3) loss of function through <italic>C9orf72</italic> haploinsufficiency.</p>
<p id="Par3">Evidence from human tissues, and cell and animal models has demonstrated that RNA foci are generated in neural cells and the G4C2 repeat structures sequester RNA-binding proteins [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. In addition, it has been shown that GA, GR, PA, PR, and GP differentially accumulate across different brain regions in ALS/FTD patients [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. However, evidence has indicated that the distribution of RNA foci and DPRs only show a minor relationship with the severity of neurodegeneration across brain regions, and DPR inclusions in disease are rarely observed in motor neurons at autopsy [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Indeed, a recent discovery demonstrated that somatic expansion of the G4C2 repeats does not occur in ALS spinal cord tissues [<xref ref-type="bibr" rid="CR41">41</xref>]. Interestingly, one group reported an ALS patient presenting with behavioural variant FTD who carried a loss-of-function splice site mutation (c.601 -2A &gt; G) that created a premature stop codon (p.I201fsX235), resulting in reduced C9orf72 mRNA levels in leukocytes relative to control cases [<xref ref-type="bibr" rid="CR31">31</xref>]. We recently reported a 90-year-old individual carrying 70 G4C2 repeats who was neurologically asymptomatic at autopsy and who had widespread accumulation of RNA foci and DPRs in the brain, but had increased C9orf72 protein levels and no TDP-43 pathology [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. These findings emphasize the importance of assessing the contribution of C9orf72 protein levels to disease mechanism. To date, reduced expression of select or total C9orf72 transcripts [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR20">20</xref>] or its protein level [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR61">61</xref>] in C9orf72 G4C2 repeat carrier-derived cells or postmortem tissues from C9-ALS/FTD patients have been widely reported. In animal models, knockdown or deletion of C9orf72 orthologues cause motor phenotypes in zebrafish [<xref ref-type="bibr" rid="CR9">9</xref>] and <italic>C. elegans</italic> [<xref ref-type="bibr" rid="CR53">53</xref>], respectively. However, loss of C9orf72 in mice does not induce motor neuron deficits, nor does it produce TDP-43 proteinopathy [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Collectively, a full understanding of C9orf72 function is needed to elucidate its contribution to the disease mechanism.</p>
<p id="Par4">Sequence and structure analyses have shown that C9orf72 shares homology with DENN (differentially expressed in normal and neoplastic cells) domain proteins [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR66">66</xref>], which are Rab GTPase guanine exchange factors (GEFs) [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. C9orf72 forms a complex with Smcr8 and Wdr41 and can act as a GEF for Rab8 and Rab39b [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Given that many Rabs show a synaptosomal distribution [<xref ref-type="bibr" rid="CR26">26</xref>] and that two studies have shown C9orf72 enrichment at synapses [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], we hypothesized that the loss of C9orf72 would lead to alterations in Rab family interactors and glutamatergic receptor levels in synaptosomes. To further understand the biochemical distribution of C9orf72 in the brain, we combined synaptosomal [<xref ref-type="bibr" rid="CR51">51</xref>] and post-synaptic density preparations [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] with a knockout-confirmed monoclonal antibody for C9orf72, which shows both biochemical and immunohistochemical specificity for C9orf72 [<xref ref-type="bibr" rid="CR28">28</xref>], to assess the distribution of C9orf72 at synaptosomes. Here, we have demonstrated that the mouse ortholog for C9orf72 (31100432021Rik) is localized to both the pre- and post-synapses and is essential for stable Rab39b and GluR1 levels in post-synaptic densities.</p>
</sec>
<sec id="Sec2">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Mouse breeding</title>
<p id="Par5">All animal protocols were conducted in accordance with the Canadian Council on Animal Care and approved by the University of Toronto Animal Care Committee. Knockout C9orf72 mice were obtained through a generous gift from Dr. Don Cleveland (UCSD) and Dr. Clothilde Lagier-Tourenne (UMass). Breeding and genotyping were conducted as previously described [<xref ref-type="bibr" rid="CR24">24</xref>]. Briefly, C9orf72 heterozygous mice (C57BL/6 background) were crossed, resulting in the production of homozygous C9orf72 KO (C9-KO) and wild-type (C9-WT) littermates. For all biochemistry and immunohistochemical experiments, 3-month old mice were empirically selected.</p>
</sec>
<sec id="Sec4">
<title>Post-synaptic density fractionation</title>
<p id="Par6">The fractionation of intact synaptosomes, followed by postsynaptic densities (PSDs), was performed as previously described [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR51">51</xref>] with some adaptations (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a). For the characterization of the distribution of protein markers in the PSD fraction of C57BL/6 WT mice, we used three biological replicates (<italic>n</italic> = 12 mice per replicate). Mice were euthanized with controlled flow CO<sub>2</sub> followed by cervical dislocation. The brains were rapidly removed from the skull and then the cerebellum and brainstem from each brain were discarded, leaving dissected forebrains for each mouse. Mouse forebrains were homogenized with a Dounce homogenizer in ice-cold homogenization buffer (HB; 320 mM sucrose, 5 mM HEPES [pH 7.4]) and then centrifuged at 1000×<italic>g</italic> for 10 min at 4 °C. The resulting pellet was homogenized with RIPA buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.4], 1% w/v TX-100, 0.5% w/v sodium deoxycholate, 1 mM EDTA, 0.1% SDS) and saved as the post-nuclear/debris fraction (P1). The supernatant (S1) was centrifuged at 13,800×<italic>g</italic> for 15 min at 4 °C. The supernatant (S2) was saved as the cytoplasmic fraction and the pellet (P2) was resuspended in ice-cold HB and then loaded onto a discontinuous Ficoll gradient (13, 9, 5% w/v) prepared in HB and centrifuged at 82,500×<italic>g</italic> for 120 min at 4 °C. Intact synaptosomes (SYN) were retrieved at the boundary between 9 and 13% in the Ficoll gradient and rinsed two times with HB. The resulting pellet was resuspended in cold resuspending buffer (RB; 0.32 M sucrose, 1 mM NaHCO<sub>3</sub>) and then lysed in an equal volume of lysis buffer 1 (LB1; 1% Triton X-100, 12 mM Tris-HCl [pH 8.1]). The lysed synaptosomes were end-over-end rotated for 15 min at 4 °C and centrifuged at 32,800×<italic>g</italic> for 20 min. The supernatant was saved as the pre-synaptic compartment (S3), whereas the pellet (P3) was resuspended in RB, loaded onto a sucrose gradient (2.0 M, 1.5 M, 1.0 M), and then centrifuged at 201,800×<italic>g</italic> for 120 min. The crude PSDs were retrieved from the 1.5–2.0 M sucrose interface and resuspended in RB, followed by treatment with equal parts lysis buffer 2 (LB2; 150 mM KCl, 1% TX-100). After end-over-end rotation for 15 min at 4 °C, the crude PSD solution was centrifuged at 201,800×<italic>g</italic> for 4 °C. The supernatant was saved as the Triton-KCl treated fraction (S4*), whereas the pellet was resuspended in RIPA buffer and sonicated at &lt; 5 watts to isolate PSDs (P4*).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Biochemical distribution of C9orf72 and Rab proteins in the pre- and post-synaptic compartments of wild-type murine forebrains. <bold>a</bold> Flowchart for the fractionation of synaptosomes, pre-synapses, and post-synaptic densities (PSDs) used in the current study. S1 = post-nuclear supernatant; P1 = nucleus and debris; S2 = crude cytoplasm; P2 = crude synaptosomes; SYN = pure synaptosomes; S3 = presynaptic terminals; P3 = crude PSDs; S4 = Triton X-100-KCl treated P3 supernatant; P4 = semi-pure PSDs; S4* = Triton X-100-KCl treated crude PSD supernatant; P4* = PSDs; PSD-IP = pure PSDs. <bold>b</bold> Distribution of markers across synaptic fractions in C57BL/6 mice. Synaptophysin (Syp); Post-Synaptic Density Protein 95 (PSD-95); TAR DNA Binding Protein 43 (TDP-43); Chromosome 9 open reading frame 72 (C9orf72); Smith-Magenis syndrome Chromosomal Region candidate gene 8 (Smcr8); Ras-related proteins Rab3a, Rab5, Rab11, Rab39b; Glutamate receptor 1 (GluR1); glutamate receptor 2 (GluR2); N-methyl-D-aspartic acid receptor 1 (NMDAR1)</p></caption><graphic id="MO1" xlink:href="40478_2019_812_Fig1_HTML"></graphic></fig></p>
<p id="Par7">To allow for the direct comparison of C9-WT versus C9-KO mice (<italic>n</italic> = 2 per sample; <italic>n</italic> = 4 biological replicates), the sucrose gradient step was omitted after resuspension of the P3 fraction, as shown in Fig. <xref ref-type="fig" rid="Fig1">1</xref>a. We implemented this approach since it was empirically determined that all markers identified in PSDs were present in semi-pure PSDs. For the C9-WT versus C9-KO experiments, P3 was treated directly with RB along with addition of LB2, as described above, followed by end-over-end rotation for 15 min at 4 °C. Centrifugation was then performed at 201,800×<italic>g</italic> for 4 °C, where the supernatant was saved as the LB2-treated fraction (S4) and the pellet was resuspended in RIPA buffer and then sonicated (&lt; 5 W) to obtain semi-pure PSDs (P4). Protein concentrations for each fraction were estimated using the bicinchoninic acid assay for electrophoretic loading.</p>
</sec>
<sec id="Sec5">
<title>PSD-95 immunoprecipitation</title>
<p id="Par8">For the immunoprecipitation (IP) experiment, the procedure for isolating PSDs was performed as described above for the characterization of protein marker distribution in PSDs (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a). We adapted our IP strategy based on an affinity-based approach in a previous study [<xref ref-type="bibr" rid="CR56">56</xref>]. Briefly, Protein A magnetic beads (Surebeads 161–4023, BioRad) were washed two times with phosphate buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na<sub>2</sub>HPO<sub>4</sub>, 1.47 mM KH<sub>2</sub>PO<sub>4</sub>, pH 7.4). Next, washed beads were incubated with either polyclonal PSD-95 antibody (ab18258) or rabbit IgG (#2729, Cell Signaling Technology) at 1:200 dilution in PBS for 1 h at ambient temperature. Beads with α-PSD-95 or rabbit IgG bound were then washed with Tris-buffered saline (TBS; 50 mM Trizma base, 150 mM NaCl, pH 7.6) with 0.1% Tween 20 three times for 5 min. Pre-sonicated P4 fractions were incubated with either PSD-95 antibody-coated beads or rabbit-IgG-coated beads for 2 h at 4 °C. Next, beads were collected by magnetic rack and washed three times for 3 min in TBS with 0.1% Tween 20. Elution was performed in RIPA buffer with sample buffer added (3X; 187.5 mM Trizma base, 6% SDS, 30% glycerol, 0.03% bromophenol blue, 15% β-mercaptoethanol, pH 7.6) with a 5 min incubation at 95 °C.</p>
</sec>
<sec id="Sec6">
<title>Gel electrophoresis and immunoblotting</title>
<p id="Par9">Samples were solubilized in sample buffer (3X) and boiled at 95 °C for 5 min for immunoblotting. All samples were electrophoresed on 10% (w/v) sodium dodecyl sulphate-polyacrylamide (SDS-PAGE) gels. Separated proteins were transferred to polyvinylidene fluoride (PVDF) membranes. For all immunoblot experiments, membranes were blocked for 1 h at ambient temperature in blocking buffer composed of 5% (w/v) skim milk powder in TBS. PVDF membranes were incubated overnight at 4 °C with primary antibodies. A complete list of primary antibodies and the appropriate methodology used is shown in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1. Membranes were then washed with TBS containing 0.05% Tween 20 and incubated for 1 h at ambient temperature with the following secondary antibodies diluted in blocking buffer: either α-mouse horseradish peroxidase (HRP)-conjugated (NA931, GE Healthcare; 1:5000), α-rabbit HRP-conjugated (NA934, GE Healthcare, 1:5000), or α-goat HRP-conjugated (sc-2433, Santa Cruz, 1:5000) antibody. Visualization of immunoblot labelling was achieved using chemiluminescence with the Western Lighting Plus ECL kit (Perkin Elmer).</p>
</sec>
<sec id="Sec7">
<title>Immunoblot image analysis and quantification</title>
<p id="Par10">Densitometric analysis of immunoblots was performed using the ImageJ distribution Fiji [<xref ref-type="bibr" rid="CR43">43</xref>]. Protein levels were estimated for each lane by calculating the relative density using an appropriate marker for that fraction (Synaptohysin [Syp] for SYN and S3; PSD-95 for P4). Bar plots were used for visualization of relative protein levels and the statistical analysis comparing C9-WT and C9-KO mice was performed with Prism (v8.0.2, GraphPad). For this, multiple t-tests were performed, and the false discovery rate was controlled using the Benjamini, Krieger, and Yekutieli procedure (Q = 1%).</p>
</sec>
<sec id="Sec8">
<title>Immunofluorescence</title>
<p id="Par11">Mice were anaesthetized with ketamine/xylazine (1 mg/g) by intraperitoneal injection. For C9orf72/PSD-95 staining, transcardial perfusion was performed with phosphate buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na<sub>2</sub>HPO<sub>4</sub>, 1.47 mM KH<sub>2</sub>PO<sub>4</sub>, pH 7.4) followed by 10% neutral buffered formalin (HT501128, Sigma-Aldrich). Brains were removed, post-fixed in formalin for exactly 24 h at ambient temperature, then placed in 70% ethanol for 1 week prior to processing and embedding in paraffin blocks. Formalin-fixed, paraffin-embedded mouse tissue blocks from C9-KO (<italic>n</italic> = 3) and C9-WT (<italic>n</italic> = 3) mice were sectioned sagittally at 6 μm and mounted on positively-charged slides. Deparaffinization was performed by placing sections on a 60 °C heat block for 20 min, in xylene (3 × 5 min), 50:50 xylene:ethanol, and then through graded ethanol washes (100, 95, 75, 50% w/v) prior to pure water. Heat-induced antigen retrieval was achieved using Tris-EDTA buffer (10 mM Trizma base, 1 mM EDTA, 0.1% Tween 20, pH 9.0) at 110 °C for 15 min in a pressure cooker. Blocking was performed with 10% donkey serum (EMD Millipore) and 0.3% TX-100 in TBS for 1 h at ambient temperature. Primary antibody incubation was performed overnight at 4 °C for C9orf72 (GTX634482; Genetex) and either PSD-95 (61–5900, Invitrogen), Synaptoporin (102,002, Synaptic Systems), or Rab39b (12162–1-AP, Proteintech) diluted in DAKO Antibody Diluent (S0809; Agilent). After 3 × 20 min washes in TBS + 0.1% Tween 20 (TBST), secondary incubation was performed at ambient temperature with donkey α-rabbit 488 and donkey α-mouse 594 Alexa Fluor secondary antibodies (Invitrogen; 1:500) diluted in DAKO Antibody Diluent. Slides were washed 3 × 20 min in TBST prior to mounting with ProLong Gold antifade reagent with 4′,6-diamidino-2-phenylindole [DAPI] (P36931; Life Technologies).</p>
<p id="Par12">For GluR1 and Rab39b labelling, transcardial perfusion was performed with ice-cold PBS followed by ice-cold 4% paraformaldehyde (PFA) in PBS. Brains were removed and post-fixed in PFA for 24 h at 4 °C. PFA-fixed brains were cryo-protected by immersion in PBS with 30% sucrose. 40 μm sagittal sections were cut on a freezing microtome (HM430, Thermo Scientific), placed in anti-freeze solution (30% glycerol, 30% ethoxyethanol, 40% PBS), and stored at − 20 °C. Sections containing the dorsal hippocampus were rehydrated in PBS and then permeablized in PBS containing 0.4% TX-100 for 20 min. Blocking was performed in 10% donkey serum (EMD Millipore) with 3% BSA in PBS containing 0.4% TX-100 for 2 h. Primary antibody incubation was performed with polyclonal rabbit α-GluR1 (AB1504; 1:200) or α-Rab39b (Proteintech; 1:2000) at 4 °C for 48 h. Following three 20 min washes with PBS containing 0.1% TX-100, sections were incubated with donkey α-rabbit 488 Alexa Fluor secondary antibody (Invitrogen; 1:500) diluted in the same blocking buffer for 2 h at ambient temperature. After three 20 min washes with PBS, sections were mounted on positively-charged slides and allowed to completely dry at ambient temperature. Mounting was then performed with ProLong Gold antifade reagent with DAPI (P36931; Life Technologies). Micrographs were captured using a Leica DMI6000B microscope with the Volocity Acquisition Suite (v6.3, Perkin Elmer).</p>
</sec>
<sec id="Sec9">
<title>Micrograph image analysis and quantification</title>
<p id="Par13">For all images, deconvolution of low and high magnification micrographs was performed with 25 iterations and a confidence level of 95% per channel using the Volocity Analysis Suite (v6.3, Perkin Elmer). For GluR1 and Rab39b, fluorescence intensity in the hippocampus of C9-WT versus C9-KO mice was calculated from exported images (<italic>n</italic> = 3 slices per biological replicate) using Fiji [<xref ref-type="bibr" rid="CR43">43</xref>]. Qualitative assessment of GluR1 levels indicated increased immunofluorescence across all hippocampal subfields, so the entire hippocampal area was outlined in the fluorescence intensity measurement. For Rab39b, the intensity was measured by outlining the mossy fiber area given the empirically determined distribution in that region alone. Mean fluorescence intensity in each case was calculated by subtracting background intensity from raw intensity and then dividing by the selected hippocampal area. Statistical analyses were performed with Prism (v8.0.2, GraphPad), where the mean fluorescent intensity of GluR1 and Rab39b in C9-WT versus C9-KO were contrasted using a paired t-test (<italic>p</italic> &lt; 0.05).</p>
</sec>
</sec>
<sec id="Sec10">
<title>Results</title>
<sec id="Sec11">
<title>C9orf72 localizes to both the pre- and post-synapses in murine forebrains</title>
<p id="Par14">Given that different Rab proteins show unique localization to the pre- and post-synaptic compartment [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR26">26</xref>], we reasoned that C9orf72 and its interacting partner Smcr8 [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR64">64</xref>] would be present in post-synaptic densities. To assess this, we performed biochemical fractionation of the pre- and post-synapses in mouse forebrains as described previously [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR51">51</xref>] with some modifications (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a). With this approach, we showed enrichment for the pre-synaptic vesicular marker synaptophysin (Syp) in synaptosomes (SYN) and the pre-synaptic compartment (S3), whereas Syp was absent in the post-synaptic fraction (P4*) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b). The established post-synaptic density marker PSD-95 was enriched in the expected fractions (SYN, P3, and P4*) and depleted in the pre-synapses (S3) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b). In addition, post-synaptic receptors GluR1, GluR2, and NMDAR1 were also enriched in P4* (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b). We also detected pre- and post-synaptic TDP-43 in S3 and P4* (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b) and found that Rab3a, Rab5, and Rab11 were enriched in the S3 fraction, but depleted in P4* (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b). However, Rab39b was found in both the pre- and post-synaptic compartments (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b), confirming the differential synaptic distribution of Rab family proteins in the brain [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Using a knockout-confirmed mouse monoclonal antibody against C9orf72 [<xref ref-type="bibr" rid="CR28">28</xref>], we detected an ~ 52 kDa band for C9orf72 corresponding to the long isoform of the protein [<xref ref-type="bibr" rid="CR61">61</xref>] in S3 and P4* (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b). We additionally found the C9orf72 interacting partner Smcr8 in S3 and P4* (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b), indicating both a pre- and post-synaptic localization of C9orf72 and Smcr8.</p>
<p id="Par15">To validate C9orf72 presence in the post-synaptic density, we performed immunoprecipitation (IP) of the PSD-95 complex on 12 pooled wild-type mouse forebrains, as previously described [<xref ref-type="bibr" rid="CR56">56</xref>] with some alterations (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a). Both the input (P4*) and IP fractions enriched for the bait protein PSD-95 (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>). Post-synaptic receptors GluR1, GluR2, and NMDAR1, in addition to TDP-43, immunoprecipitated with PSD-95 (Fig. <xref ref-type="fig" rid="Fig2">2</xref>a), whereas the established contaminants neurofilament light chain (Nefl) and glial fibrillary acidic protein (Gfap) [<xref ref-type="bibr" rid="CR56">56</xref>] were absent from the PSD IP (Fig. <xref ref-type="fig" rid="Fig2">2</xref>a). Notably, C9orf72 was detected in the PSD IP, along with its interacting partners Smcr8 and Rab39b (Fig. <xref ref-type="fig" rid="Fig2">2</xref>a). To confirm the brain region localization of synaptic C9orf72, we performed double immunofluorescence labelling with antibody to C9orf72 with either a pre- (Synpr) or post-synaptic (PSD-95) marker on sagittal sections in C9-WT and C9-KO mice. Low magnification images indicated that C9orf72 was present in the forebrain regions that we and others previously identified [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], including mossy fiber synapses of the hippocampus (Fig. <xref ref-type="fig" rid="Fig2">2</xref>b), the glomerular layer of the olfactory bulb, synapses of the basal ganglia, substantia nigra, and inferior olive, and in the granular layer of the cerebellum (data not shown). We detected partial overlap of C9orf72 with both pre-synaptic (Synpr) and post-synaptic (PSD-95) markers in the mossy fiber area of the dorsal hippocampus, whereas this synaptic C9orf72 signal was ablated in C9-KO mice (Fig. <xref ref-type="fig" rid="Fig2">2</xref>b). Deconvoluted, high magnification images from C9-WT mossy fiber synapses demonstrated partial overlap of C9orf72 with pre-synaptic (Synpr), post-synaptic (PSD-95), and dendritic (MAP 2) proteins (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c). Furthermore, high-powered micrographs also confirmed that C9orf72 was partially co-localized with Rab39b in the mossy fiber synapse region of C9-WT mice (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c), indicating that C9orf72 shares synaptic localization with previously identified interactors.
<fig id="Fig2"><label>Fig. 2</label><caption><p>C9orf72 and Rab39b are localized to post-synaptic densities. <bold>a</bold> Immunoblot analysis of affinity purified PSD-95 complexes from C9-WT mice. PSD = PSD-95 antibody; UB = unbound fraction; IgG = rabbit IgG; wash = last wash. Synaptophysin (Syp); Post-Synaptic Density Protein 95 (PSD95); TAR DNA Binding Protein 43 (TDP-43); Chromosome 9 open reading frame 72 (C9orf72); Smith-Magenis syndrome Chromosomal Region candidate gene 8 (Smcr8); Ras-related proteins Rab3a, Rab5, Rab11, Rab39b; Glutamate receptor 1 (GluR1); glutamate receptor 2 (GluR2); N-methyl-D-aspartic acid receptor 1 (NMDAR1). Glial fibrillary acid protein (Gfap); Neurofilament Light Chain (Nefl). <bold>b</bold> Low magnification immunofluorescent micrographs of C9orf72, PSD-95, and DAPI or C9orf72, Synaptoporin (Synpr), and DAPI in the dorsal hippocampus of C9-WT and C9-KO mice. Scale = 200 μm. <bold>c</bold> High magnification immunofluorescent micrographs of C9orf72 with either PSD-95, microtubule associated protein 2 (MAP2), Synpr, or Rab39b in the CA3 region of the hippocampus from C9-WT and C9-KO mice. Insets contain arrowheads which indicate co-detection of fluorescent signal between the red and green channels. Scale = 20 μm</p></caption><graphic id="MO2" xlink:href="40478_2019_812_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec12">
<title>Synaptosomal and pre-synaptic preparations are unchanged in C9-KO versus C9-WT mice</title>
<p id="Par16">Given that C9orf72 localized to both pre- and post-synaptic regions, we hypothesized that Rab family members, Smcr8, and synaptic receptor protein levels would show alterations in C9-KO versus C9-WT mice. We purified intact synaptosome from C9-WT and C9-KO mouse forebrains and then released the pre-synaptic compartment using Triton X-100 (S3) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a). Consistent protein loading was shown by stable GAPDH levels across input fractions (S1) in C9-WT and C9-KO mice. As expected, C9orf72 was absent in S1 from C9-KO mice along with undetectable Smcr8 protein levels (Fig. <xref ref-type="fig" rid="Fig3">3</xref>a), which is in line with previous C9orf72 knockout studies in vitro [<xref ref-type="bibr" rid="CR67">67</xref>] and in vivo [<xref ref-type="bibr" rid="CR55">55</xref>]. However, Rab39b and GluR1 were unchanged between C9-WT and C9-KO in the S1 fraction (Fig. <xref ref-type="fig" rid="Fig3">3</xref>a), which was verified by densitometric quantification (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1). In synaptosomal (SYN) fractions, we detected stable levels of TDP-43, Rab5, Rab11, Rab39b, GluR1, GluR2, and NMDAR1 between C9-WT and C9-KO mice (Fig. <xref ref-type="fig" rid="Fig3">3</xref>b), which was quantified by densitometric analysis from Syp-corrected SYN preparations (Fig. <xref ref-type="fig" rid="Fig3">3</xref>b, c). Interestingly, Rab3a levels were significantly increased in C9-KO synaptosomes compared with C9-WT (Q &lt; 0.01; Fig. <xref ref-type="fig" rid="Fig3">3</xref>b, c), indicating that loss of C9orf72 expression in C9-KO mice results in a compensatory increase in Rab3a levels in the pre-synaptic compartment. However, we found that Rab3a levels were unchanged in S3 between C9-WT and C9-KO mice (Fig. <xref ref-type="fig" rid="Fig4">4</xref>a), which we further confirmed by densitometric quantification (Fig. <xref ref-type="fig" rid="Fig4">4</xref>b). In the S3 fraction, the levels of TDP-43, Rab5, Rab11, Rab39b, GluR1, GluR2, and NMDAR1 were also unchanged between C9-WT and C9-KO mice (Fig. <xref ref-type="fig" rid="Fig4">4</xref>a, b), indicating that pre-synaptic Rab family members show stable levels in the absence of C9orf72.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Rab3a protein levels are increased in the synaptosomal fraction of C9-KO mice relative to C9-WT mice. <bold>a</bold> Immunoblots from the post-nuclear input fraction (S1) from C9-WT and C9-KO mice (<italic>n</italic> = 2 mice per sample; <italic>n</italic> = 4 biological replicates per group). Loading confirmed by glyceraldehyde 3-phosphate dehydrogenase (GAPDH); Chromosome 9 open reading frame 72 (C9orf72); Smith-Magenis syndrome Chromosomal Region candidate gene 8 (Smcr8); Ras-related protein Rab39b; Glutamate receptor 1 (GluR1). <bold>b</bold> Immunoblots from the synaptosomal (SYN) fraction. <bold>c</bold> Bar plots of mean immunoblot band density for each antibody probed in the SYN fraction. x-axis = C9-WT versus C9-KO for each antibody; y-axis = relative density (ratio relative to wild-type); error bars = standard deviation; *Q&lt;0.01. Synaptophysin (Syp); Post-Synaptic Density Protein 95 (PSD95); TAR DNA Binding Protein 43 (TDP-43); Rab family members Rab3a, Rab5, Rab11, Rab39b; Glutamate receptor 1 (GluR1); glutamate receptor 2 (GluR2); N-methyl-D-aspartic acid receptor 1 (NMDAR1)</p></caption><graphic id="MO3" xlink:href="40478_2019_812_Fig3_HTML"></graphic></fig>
<fig id="Fig4"><label>Fig. 4</label><caption><p>Pre-synaptic fraction shows stable protein levels between C9-WT and C9-KO mice. <bold>a</bold> Immunoblots from the pre-synaptic compartment (S3) from C9-WT and C9-KO mice (<italic>n</italic> = 2 mice per sample; <italic>n</italic> = 4 biological replicates per group). <bold>b</bold> Bar plots of mean S3 immunoblot band densities for each antibody probed in the S3 fraction. y-axis = relative density; error bars = standard deviation. Synaptophysin (Syp); TAR DNA Binding Protein 43 (TDP-43); Chromosome 9 open reading frame 72 (C9orf72); Smith-Magenis syndrome Chromosomal Region candidate gene 8 (Smcr8); Ras-related proteins Rab3a, Rab5, Rab11, Rab39b; Glutamate receptor 1 (GluR1); glutamate receptor 2 (GluR2); N-methyl-D-aspartic acid receptor 1 (NMDAR1)</p></caption><graphic id="MO4" xlink:href="40478_2019_812_Fig4_HTML"></graphic></fig></p>
</sec>
<sec id="Sec13">
<title>Loss of C9orf72 results in decreased Rab39b and increased GluR1 in the hippocampus of C9-KO mice</title>
<p id="Par17">We asked whether loss of C9orf72 would lead to alterations in post-synaptic Rab39b and receptor protein levels. For this we performed an immunoblot analysis on semi-pure post-synaptic density preparations (P4; Fig. <xref ref-type="fig" rid="Fig1">1</xref>a) from C9-WT and C9-KO mice. We detected stable PSD-95 between C9-WT and C9-KO mice (Fig. <xref ref-type="fig" rid="Fig5">5</xref>a), which we verified by densitometry, and then used PSD-95 protein levels to estimate relative abundance for the other markers screened in P4 (Fig. <xref ref-type="fig" rid="Fig5">5</xref>b). We observed stable TDP-43, GluR2, and NMDAR1 levels in P4 and undetectable Smcr8 levels in C9-KO preparations (Fig. <xref ref-type="fig" rid="Fig5">5</xref>a, b), whereas the relative amount of Rab39b was decreased and GluR1 was increased in P4 from C9-KO versus C9-WT mice (Q &lt; 0.01; Fig. <xref ref-type="fig" rid="Fig5">5</xref>a, b). We next assessed the immunofluorescence intensity of Rab39b and GluR1 in 40 μm free-floating sections from C9-WT and C9-KO mouse brains. There was a concomitant decrease in Rab39b (Fig. <xref ref-type="fig" rid="Fig5">5</xref>c) with upregulated GluR1 protein levels (Fig. <xref ref-type="fig" rid="Fig5">5</xref>d) in the hippocampus of C9-KO versus C9-WT mice. After quantification, we found a significant decrease in Rab39b fluorescence intensity in the mossy fiber synapse region of C9-KO over C9-WT mice (<italic>p</italic> &lt; 0.001; Fig. <xref ref-type="fig" rid="Fig5">5</xref>e), in agreement with the changes found by immunoblot in P4 (Fig. <xref ref-type="fig" rid="Fig5">5</xref>a). We did not detect a significant decrease of Rab39b in the other brain regions where we detected synaptic C9orf72, such as the glomerular layer of the olfactory bulb, synapses of the basal ganglia, substantia nigra, and inferior olive, and in the granular layer of the cerebellum (data not shown). For GluR1, we found a significant increase in fluorescence intensity in the entire dorsal hippocampus (<italic>p</italic> &lt; 0.05; Fig. <xref ref-type="fig" rid="Fig5">5</xref>f), indicating that C9orf72 is required for the proper regulation of hippocampal GluR1 levels in vivo.
<fig id="Fig5"><label>Fig. 5</label><caption><p>Rab39b and GluR1 levels are reciprocally altered in the post-synaptic compartment of C9-KO mice. <bold>a</bold> Western blot analysis of pre-synaptic density fractions (P4) from C9-WT and C9-KO mice (<italic>n</italic> = 2 mice per sample; <italic>n</italic> = 4 biological replicates per group). Post-Synaptic Density Protein 95 (PSD95); TAR DNA Binding Protein 43 (TDP-43); Chromosome 9 open reading frame 72 (C9orf72); Smith-Magenis syndrome Chromosomal Region candidate gene 8 (Smcr8); Ras-related proteins Rab39b; Glutamate receptor 1 (GluR1); glutamate receptor 2 (GluR2); N-methyl-D-aspartic acid receptor 1 (NMDAR1). <bold>b</bold> Bar plots of mean immunoblot band density for each antibody probed in the P4 fraction. x-axis = C9-WT versus C9-KO for each antibody; y-axis = relative density (ratio relative to wild-type); error bars = standard deviation; *Q&lt;0.01. Representative immunofluorescent micrographs of <bold>c</bold> Rab39b and <bold>d</bold> GluR1 in the dorsal hippocampus of C9-WT versus C9-WT mice. Scale = 200 μm. Quantification of <bold>e</bold> Rab39b and <bold>f</bold> GluR1 fluorescence intensity in the dorsal hippocampus of C9-WT versus C9-WT mice (<italic>n</italic> = 4 animals; <italic>n</italic> = 3 micrographs per animal); y-axis = relative fluorescence intensity as a percentage (%) of C9-WT #p&lt;0.001 for Rab39b; #p&lt;0.05 for GluR1</p></caption><graphic id="MO5" xlink:href="40478_2019_812_Fig5_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec14">
<title>Discussion</title>
<p id="Par18">The elucidation of C9orf72 function remains a crucial research endeavor. The present study explored the effect of in vivo knockout of C9orf72 on pre- and post-synaptic protein expression of C9orf72 interactors such as Smcr8 and Rab family proteins, and on post-synaptic receptor levels. Here we show both biochemical and immunohistochemical evidence that C9orf72 localizes to both the pre- and post-synaptic compartment in the mouse forebrain. Our biochemical results also showed that Smcr8 is present in both the pre- and post-synaptic compartments, and recapitulated previous findings showing that loss of C9orf72 expression results in complete ablation of Smcr8 protein expression in the forebrain (Ugolino, 2016). Our immunoblot studies further showed that Rab3a, Rab5, and Rab11 were localized to the pre-synaptic compartment, and that Rab39b is present in both the pre- and post-synapse. In C9-KO mice, PSDs in the hippocampus demonstrated a concomitant decrease in Rab39b levels with increased GluR1 when compared with C9-WT mice. However, we could not detect any protein level changes between C9-WT and C9-KO mice for GluR2 and NMDAR1 in PSDs. Overall, these results suggest that post-synaptic localization of C9orf72 together with its Rab GTPase Rab39b are important for the regulation of glutamatergic receptor levels in vivo.</p>
<p id="Par19">Interestingly, loss-of-function <italic>RAB39B</italic> mutations are causative of both X-linked mental retardation, showing comorbidity with autism spectrum disorder and epilepsy [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR58">58</xref>], and early onset Parkinson’s disease with synucleinopathy [<xref ref-type="bibr" rid="CR58">58</xref>]. RAB39B is important for the coordination of AMPA receptor subunit (GluR1–4) composition and trafficking to the post-synaptic membrane [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Here, we demonstrated the co-detection of Rab39b with C9orf72 in the hippocampal mossy fiber region of the mouse forebrain, which is similar to a previous study showing RAB39B overlap with C9orf72 in human iPSC-derived motor neurons [<xref ref-type="bibr" rid="CR16">16</xref>]. It has also been shown that knockdown of Rab39b in primary neuron cultures results in increased GluR1 trafficking to dendrites [<xref ref-type="bibr" rid="CR36">36</xref>]. The current study found that a decrease in Rab39b coincides with increased GluR1 in hippocampal PSDs of C9-KO mice. Hence, this work provides in vivo evidence for a link between post-synaptic C9orf72 and its effect on the protein levels of Rab39b and GluR1 in PSDs.</p>
<p id="Par20">Although C9-KO mice do not demonstrate an overt behavioural phenotype, we showed that loss of the C9orf72 gene leads to alterations in AMPA subunit levels in the murine hippocampus. AMPA receptor/glutamatergic-associated excitotoxicity is a widely studied disease mechanism underlying ALS [<xref ref-type="bibr" rid="CR5">5</xref>], FTD [<xref ref-type="bibr" rid="CR7">7</xref>], and ALS/FTD [<xref ref-type="bibr" rid="CR49">49</xref>]. In addition to increased GluR1 levels demonstrated in C9-KO mice here, upregulation of GluR1 has been observed in other models, such as cultured neurons from SOD1<sup>G93A</sup> [<xref ref-type="bibr" rid="CR46">46</xref>] and TDP43<sup>A315T</sup> [<xref ref-type="bibr" rid="CR25">25</xref>] transgenic mice that also showed heightened sensitivity to glutamate. Furthermore, increased sensitivity to glutamate has been observed in iPSC-derived neurons from C9-ALS/FTD patients [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Our current findings are in line with a study demonstrating an increase of GluR1 transcript and protein levels with a decreased GluR2 level in iPSC-derived motor neurons from C9-ALS patients [<xref ref-type="bibr" rid="CR45">45</xref>]. While we did not observe an alteration in GluR2 levels in PSD preparations from C9-KO mice, our results indicate that loss of the C9orf72 gene has specific brain region and synaptic subtype effects on AMPA receptor subunit composition in vivo. Another study showed increased GluR1 and NMDAR1 in human C9-ALS post-mortem motor cortices by immunofluorescence and in PSD preparations [<xref ref-type="bibr" rid="CR47">47</xref>]. In partial agreement with our study, this study also showed that GluR1 was increased in spinal cord motor neurons from C9-KO mice [<xref ref-type="bibr" rid="CR47">47</xref>]. More recently NMDAR1 and GluR6/7 levels were shown to be increased in the hippocampus of C9orf72 heterozygous mice [<xref ref-type="bibr" rid="CR48">48</xref>], indicating that decreasing C9orf72 expression is sufficient to alter glutamatergic receptor levels in vivo. Collectively, the results of these studies and our own converge on glutamatergic excitotoxicity as a potentially important aspect of disease mechanism in both the brain and spinal cord of C9-ALS/FTD.</p>
</sec>
<sec id="Sec15">
<title>Conclusion</title>
<p id="Par21">The present study revealed C9orf72 expression to be an important factor in post-synaptic receptor expression in vivo. We demonstrate a novel localization of C9orf72 to PSDs together with its interactor Smcr8. We also show that loss of C9orf72 in mice results in decreased Rab39b expression and increased GluR1 levels in the hippocampus. Future studies will assess the functional association between post-synaptic C9orf72 and Rab39b protein levels on AMPA receptor trafficking. A better understanding of glutamatergic excitotoxicity in C9-ALS/FTD and in non-C9 ALS/FTD may lead to novel therapeutic development.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional file</title>
<sec id="Sec16">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="40478_2019_812_MOESM1_ESM.docx"><caption><p><bold>Additional file 1: Table S1.</bold> Primary antibodies used in the current study. <bold>Figure S1.</bold> Rab39b and GluR1 protein levels are unchanged in S1 fraction between C9-WT and C9-KO mice. Bar plots of mean S1 immunoblot band densities for (GAPDH); Ras-related protein Rab39b; Glutamate receptor 1 (GluR1). y-axis = relative density; error bars = standard deviation. All pairwise comparisons are not significant.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>Shangxi Xiao and Paul M. McKeever contributed equally to this work.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s40478-019-0812-5.</p>
</sec>
<ack>
<p>We thank Dr. Don Cleveland (UCSD) and Dr. Clothilde Lagier-Tourenne (UMass) for the C9orf72 knockout mice. We thank Dr. Philip McGoldrick for valuable discussion and input. We also thank Tanz CRND members Rosemary Ahrens, Tammy Langman, and Zhilan Wang for their technical assistance.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>SX: devised experimental design and analysis, performed synaptosome and post synaptic density preparations, conducted post synaptic density immunoprecipitation, performed Western blots, wrote and edited the manuscript. PMM: devised experimental design and analysis, performed synaptosome and postsynaptic density preparations, analyzed Western blot data, conducted immunofluorescence/microscopy studies, statistical analyses, wrote and edited manuscript. AL: devised experimental design and analysis, maintenance of animal lines, wrote and edited the manuscript. JR: supervision of project, devised experimental design and analysis, wrote and edited the manuscript. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This work was funded by an ALS Canada-Brain Canada Arthur J. Hudson Translational Team Grant and the James Hunter and Family ALS Initiative. PMM is supported by the ALS Association Milton Safenowitz Postdoctoral Fellowship.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par22">No human subjects were involved in this study, so this is not applicable.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par23">Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par24">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gascon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>DeGroot</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tapper</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Sellier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Charlet-Berguerand</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Karydas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Boxer</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F-B</given-names>
</name>
</person-group>
<article-title>Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons</article-title>
<source/>Acta Neuropathol
          <year>2013</year>
<volume>126</volume>
<fpage>385</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1149-y</pub-id>
<pub-id pub-id-type="pmid">23836290</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Sarraj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>King</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Troakes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Maekawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bodi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Rogelj</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Al-Chalabi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hortobágyi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>CE</given-names>
</name>
</person-group>
<article-title>p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS</article-title>
<source/>Acta Neuropathol
          <year>2011</year>
<volume>122</volume>
<fpage>691</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-011-0911-2</pub-id>
<pub-id pub-id-type="pmid">22101323</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ash</surname>
<given-names>PEA</given-names>
</name>
<name>
<surname>Bieniek</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Caulfield</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W-L</given-names>
</name>
<name>
<surname>DeJesus-Hernandez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Blitterswijk</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Jansen-West</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Boylan</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS</article-title>
<source/>Neuron
          <year>2013</year>
<volume>77</volume>
<fpage>639</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.004</pub-id>
<pub-id pub-id-type="pmid">23415312</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<mixed-citation publication-type="other">Atkinson RAK, Fernandez-Martos CM, Atkin JD, Vickers JC, King AE (2015) C9ORF72 expression and cellular localization over mouse development. Acta Neuropathologica Communications 3. 10.1186/s40478-015-0238-7</mixed-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bae</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vucic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kiernan</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>The puzzling case of Hyperexcitability in amyotrophic lateral sclerosis</article-title>
<source/>J Clin Neurol
          <year>2013</year>
<volume>9</volume>
<fpage>65</fpage>
<pub-id pub-id-type="doi">10.3988/jcn.2013.9.2.65</pub-id>
<pub-id pub-id-type="pmid">23626643</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belzil</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>PO</given-names>
</name>
<name>
<surname>Prudencio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Stetler</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>IK</given-names>
</name>
<name>
<surname>Pregent</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Daughrity</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Boylan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood</article-title>
<source/>Acta Neuropathol
          <year>2013</year>
<volume>126</volume>
<fpage>895</fpage>
<lpage>905</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1199-1</pub-id>
<pub-id pub-id-type="pmid">24166615</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<mixed-citation publication-type="other">Benussi A, Alberici A, Buratti E, Ghidoni R, Gardoni F, Di Luca M, Padovani A, Borroni B (2019) Toward a glutamate hypothesis of Frontotemporal dementia. Front Neurosci 13. 10.3389/fnins.2019.00304</mixed-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlin</surname>
<given-names>RK</given-names>
</name>
</person-group>
<article-title>Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities</article-title>
<source/>J Cell Biol
          <year>1980</year>
<volume>86</volume>
<fpage>831</fpage>
<lpage>845</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.86.3.831</pub-id>
<pub-id pub-id-type="pmid">7410481</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<mixed-citation publication-type="other">Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A, Kabashi E (2013) Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis: Annals of Neurology Vol 73 No 6 June 2013. Annals of Neurology n/a-n/a. 10.1002/ana.23946</mixed-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The structure of postsynaptic densities isolated from dog cerebral cortex: I. overall morphology and protein composition</article-title>
<source/>J Cell Biol
          <year>1977</year>
<volume>74</volume>
<fpage>181</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.74.1.181</pub-id>
<pub-id pub-id-type="pmid">194906</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corbier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sellier</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>C9ORF72 is a GDP/GTP exchange factor for Rab8 and Rab39 and regulates autophagy</article-title>
<source/>Small GTPases
          <year>2017</year>
<volume>8</volume>
<fpage>181</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1080/21541248.2016.1212688</pub-id>
<pub-id pub-id-type="pmid">27494456</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davidson</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Troakes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rollinson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Masuda-Suzukake</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nonaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hamdalla</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ealing</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pickering-Brown</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Snowden</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>DMA</given-names>
</name>
</person-group>
<article-title>Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in <italic>C9orf72</italic> is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins</article-title>
<source/>Neuropathol Appl Neurobiol
          <year>2016</year>
<volume>42</volume>
<fpage>242</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1111/nan.12292</pub-id>
<pub-id pub-id-type="pmid">26538301</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<mixed-citation publication-type="other">Davidson YS, Barker H, Robinson AC, Thompson JC, Harris J, Troakes C, Smith B, Al-Saraj S, Shaw C, Rollinson S, Masuda-Suzukake M, Hasegawa M, Pickering-Brown S, Snowden JS, Mann DM (2014) Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun 2. 10.1186/2051-5960-2-70</mixed-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeJesus-Hernandez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mackenzie</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Boeve</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Boxer</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rutherford</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Finch</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Flynn</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Adamson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kouri</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wojtas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sengdy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hsiung</surname>
<given-names>G-YR</given-names>
</name>
<name>
<surname>Karydas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Josephs</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Knopman</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Boylan</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Graff-Radford</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Expanded GGGGCC Hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS</article-title>
<source/>Neuron
          <year>2011</year>
<volume>72</volume>
<fpage>245</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.011</pub-id>
<pub-id pub-id-type="pmid">21944778</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donnelly</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P-W</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Haeusler</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Mistry</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Vidensky</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Daley</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Poth</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Hoover</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fines</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Maragakis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tienari</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Traynor</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rigo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Blackshaw</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sattler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention</article-title>
<source/>Neuron
          <year>2013</year>
<volume>80</volume>
<fpage>415</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.015</pub-id>
<pub-id pub-id-type="pmid">24139042</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<mixed-citation publication-type="other">Frick P, Sellier C, Mackenzie IRA, Cheng C-Y, Tahraoui-Bories J, Martinat C, Pasterkamp RJ, Prudlo J, Edbauer D, Oulad-Abdelghani M, Feederle R, Charlet-Berguerand N, Neumann M (2018) Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol Commun 6. 10.1186/s40478-018-0579-0</mixed-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gami</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schottlaender</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bettencourt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Pablo</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Mudanohwo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mizielinska</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Polke</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Holton</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Isaacs</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Houlden</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Revesz</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lashley</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical disease</article-title>
<source/>Acta Neuropathol
          <year>2015</year>
<volume>130</volume>
<fpage>599</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-015-1473-5</pub-id>
<pub-id pub-id-type="pmid">26347457</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Bieniek</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y-J</given-names>
</name>
<name>
<surname>Jansen-West</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ash</surname>
<given-names>PEA</given-names>
</name>
<name>
<surname>Caulfield</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Daughrity</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dunmore</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Castanedes-Casey</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cosio</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>van Blitterswijk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Boylan</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS</article-title>
<source/>Acta Neuropathol
          <year>2013</year>
<volume>126</volume>
<fpage>829</fpage>
<lpage>844</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1192-8</pub-id>
<pub-id pub-id-type="pmid">24129584</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giannandrea</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mignogna</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Sirri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carrabino</surname>
<given-names>S</given-names>
</name>
<name>
<surname>D’Elia</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vecellio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cogliati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Larizza</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ropers</surname>
<given-names>H-H</given-names>
</name>
<name>
<surname>Tzschach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kalscheuer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Oehl-Jaschkowitz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Gecz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Van Esch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Raynaud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chelly</surname>
<given-names>J</given-names>
</name>
<name>
<surname>de Brouwer</surname>
<given-names>APM</given-names>
</name>
<name>
<surname>Toniolo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>D’Adamo</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>86</volume>
<fpage>185</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.01.011</pub-id>
<pub-id pub-id-type="pmid">20159109</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gijselinck</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Van Langenhove</surname>
<given-names>T</given-names>
</name>
<name>
<surname>van der Zee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sleegers</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Philtjens</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kleinberger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Janssens</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bettens</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Van Cauwenberghe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pereson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Engelborghs</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sieben</surname>
<given-names>A</given-names>
</name>
<name>
<surname>De Jonghe</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vandenberghe</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Santens</surname>
<given-names>P</given-names>
</name>
<name>
<surname>De Bleecker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bäumer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dillen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Joris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cuijt</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Corsmit</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Elinck</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Van Dongen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Van den Broeck</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vaerenberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mattheijssens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peeters</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Robberecht</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cras</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J-J</given-names>
</name>
<name>
<surname>De Deyn</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Cruts</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van Broeckhoven</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study</article-title>
<source/>Lancet Neurol
          <year>2012</year>
<volume>11</volume>
<fpage>54</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(11)70261-7</pub-id>
<pub-id pub-id-type="pmid">22154785</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gitler</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Tsuiji</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>There has been an awakening: emerging mechanisms of C9orf72 mutations in FTD/ALS</article-title>
<source/>Brain Res
          <year>2016</year>
<volume>1647</volume>
<fpage>19</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2016.04.004</pub-id>
<pub-id pub-id-type="pmid">27059391</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hausser</surname>
<given-names>Angelika</given-names>
</name>
<name>
<surname>Schlett</surname>
<given-names>Katalin</given-names>
</name>
</person-group>
<article-title>Coordination of AMPA receptor trafficking by Rab GTPases</article-title>
<source/>Small GTPases
          <year>2017</year>
<volume>10</volume>
<issue>6</issue>
<fpage>419</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1080/21541248.2017.1337546</pub-id>
<pub-id pub-id-type="pmid">28628388</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iyer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Acharya</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>A comparative bioinformatic analysis of <italic>C9orf72</italic></article-title>
<source/>PeerJ
          <year>2018</year>
<volume>6</volume>
<fpage>e4391</fpage>
<pub-id pub-id-type="doi">10.7717/peerj.4391</pub-id>
<pub-id pub-id-type="pmid">29479499</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Saberi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McAlonis-Downes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seelman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stauffer</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Jafar-nejad</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Drenner</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>S-C</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Engelhardt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baughn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Platoshyn</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Marsala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heyser</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Ard</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>De Muynck</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Daughrity</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Swing</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Tessarollo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Delpoux</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Utzschneider</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Hedrick</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>de Jong</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Edbauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Van Damme</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Da Cruz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ravits</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rigo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Lagier-Tourenne</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs</article-title>
<source/>Neuron
          <year>2016</year>
<volume>90</volume>
<fpage>535</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.006</pub-id>
<pub-id pub-id-type="pmid">27112497</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Handley</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brizuela</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dawkins</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>KEA</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Blizzard</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function</article-title>
<source/>Dis Model Mech
          <year>2019</year>
<volume>12</volume>
<fpage>dmm038109</fpage>
<pub-id pub-id-type="doi">10.1242/dmm.038109</pub-id>
<pub-id pub-id-type="pmid">31036551</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiral</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Kohrs</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Hiesinger</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Rab GTPases and membrane trafficking in Neurodegeneration</article-title>
<source/>Curr Biol
          <year>2018</year>
<volume>28</volume>
<fpage>R471</fpage>
<lpage>R486</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2018.02.010</pub-id>
<pub-id pub-id-type="pmid">29689231</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koppers</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blokhuis</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Westeneng</surname>
<given-names>H-J</given-names>
</name>
<name>
<surname>Terpstra</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Zundel</surname>
<given-names>CAC</given-names>
</name>
<name>
<surname>Vieira de Sá</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schellevis</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Waite</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Veldink</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Pasterkamp</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits: C9orf72 ablation</article-title>
<source/>Ann Neurol
          <year>2015</year>
<volume>78</volume>
<fpage>426</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1002/ana.24453</pub-id>
<pub-id pub-id-type="pmid">26044557</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<mixed-citation publication-type="other">Laflamme C, McKeever P, Kumar R, Schwartz J, Chen CX-Q, You Z, Xiao S, Benaliouad F, Gileadi O, McBride HM, Durcan TM, Edwards A, Robertson J, McPherson P (2019) Implementation of an antibody characterization process: application to the major ALS/FTD disease gene C9ORF72. bioRxiv. 10.1101/499350</mixed-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levine</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Gatta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs</article-title>
<source/>Bioinformatics
          <year>2013</year>
<volume>29</volume>
<fpage>499</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts725</pub-id>
<pub-id pub-id-type="pmid">23329412</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ling</surname>
<given-names>S-C</given-names>
</name>
<name>
<surname>Polymenidou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis</article-title>
<source/>Neuron
          <year>2013</year>
<volume>79</volume>
<fpage>416</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.033</pub-id>
<pub-id pub-id-type="pmid">23931993</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>CX</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>XN</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>XG</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Identification of a novel loss-of-function C9orf72 splice site mutation in a patient with amyotrophic lateral sclerosis</article-title>
<source/>Neurobiol Aging
          <year>2016</year>
<volume>47</volume>
<fpage>219.e1</fpage>
<lpage>219.e5</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2016.07.027</pub-id>
<pub-id pub-id-type="pmid">27595458</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackenzie</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Arzberger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kremmer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Troost</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lorenzl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>S-M</given-names>
</name>
<name>
<surname>Haass</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Edbauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations</article-title>
<source/>Acta Neuropathol
          <year>2013</year>
<volume>126</volume>
<fpage>859</fpage>
<lpage>879</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1181-y</pub-id>
<pub-id pub-id-type="pmid">24096617</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackenzie</surname>
<given-names>IRA</given-names>
</name>
<name>
<surname>Frick</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Grässer</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cashman</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Edbauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kremmer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Prudlo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Troost</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers</article-title>
<source/>Acta Neuropathol
          <year>2015</year>
<volume>130</volume>
<fpage>845</fpage>
<lpage>861</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-015-1476-2</pub-id>
<pub-id pub-id-type="pmid">26374446</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marat</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Dokainish</surname>
<given-names>H</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>DENN domain proteins: regulators of Rab GTPases</article-title>
<source/>J Biol Chem
          <year>2011</year>
<volume>286</volume>
<fpage>13791</fpage>
<lpage>13800</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.R110.217067</pub-id>
<pub-id pub-id-type="pmid">21330364</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGoldrick</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Blitterswijk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>McKeever</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Weichert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Keith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Unaffected mosaic <italic>C9orf72</italic> case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression</article-title>
<source/>Neurology
          <year>2018</year>
<volume>90</volume>
<fpage>e323</fpage>
<lpage>e331</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000004865</pub-id>
<pub-id pub-id-type="pmid">29282338</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<mixed-citation publication-type="other">Mignogna ML, Giannandrea M, Gurgone A, Fanelli F, Raimondi F, Mapelli L, Bassani S, Fang H, Van Anken E, Alessio M, Passafaro M, Gatti S, Esteban JA, Huganir R, D’Adamo P (2015) The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition. Nat Commun 6. 10.1038/ncomms7504</mixed-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizielinska</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lashley</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Norona</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Clayton</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Ridler</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Fratta</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Isaacs</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci</article-title>
<source/>Acta Neuropathol
          <year>2013</year>
<volume>126</volume>
<fpage>845</fpage>
<lpage>857</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1200-z</pub-id>
<pub-id pub-id-type="pmid">24170096</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Arzberger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Grässer</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Gijselinck</surname>
<given-names>I</given-names>
</name>
<name>
<surname>May</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rentzsch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>S-M</given-names>
</name>
<name>
<surname>Schludi</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>van der Zee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cruts</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van Broeckhoven</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kremmer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Haass</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Edbauer</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins</article-title>
<source/>Acta Neuropathol
          <year>2013</year>
<volume>126</volume>
<fpage>881</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-013-1189-3</pub-id>
<pub-id pub-id-type="pmid">24132570</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>S-M</given-names>
</name>
<name>
<surname>Arzberger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>May</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rentzsch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kremmer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Cruts</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van Broeckhoven</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Haass</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Edbauer</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<fpage>1335</fpage>
<lpage>1338</lpage>
<pub-id pub-id-type="doi">10.1126/science.1232927</pub-id>
<pub-id pub-id-type="pmid">23393093</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renton</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Majounie</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Waite</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Simón-Sánchez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rollinson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Schymick</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Laaksovirta</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Myllykangas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kalimo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Paetau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abramzon</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Remes</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kaganovich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Duckworth</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Harmer</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ryten</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Trabzuni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guerreiro</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Orrell</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Neal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Sondervan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Seelaar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Halliwell</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Callister</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Toulson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gerhard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Snowden</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Neary</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nalls</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Peuralinna</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jansson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Isoviita</surname>
<given-names>V-M</given-names>
</name>
<name>
<surname>Kaivorinne</surname>
<given-names>A-L</given-names>
</name>
<name>
<surname>Hölttä-Vuori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ikonen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sulkava</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Benatar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wuu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chiò</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Restagno</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Borghero</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sabatelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Heckerman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Sendtner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Drepper</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Alkan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Abdullaev</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Pack</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Dutra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pak</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Heutink</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pickering-Brown</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Tienari</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Traynor</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>A Hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD</article-title>
<source/>Neuron
          <year>2011</year>
<volume>72</volume>
<fpage>257</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.010</pub-id>
<pub-id pub-id-type="pmid">21944779</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Leblond</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Catoire</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Volkening</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Strong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dion</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Somatic expansion of the <italic>C9orf72</italic> hexanucleotide repeat does not occur in ALS spinal cord tissues</article-title>
<source/>Neurol Genet
          <year>2019</year>
<volume>5</volume>
<fpage>e317</fpage>
<pub-id pub-id-type="doi">10.1212/NXG.0000000000000317</pub-id>
<pub-id pub-id-type="pmid">31041398</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saberi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stauffer</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ohkubo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schloffman</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Maldonado</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baughn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Pizzo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ravits</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis</article-title>
<source/>Acta Neuropathol
          <year>2018</year>
<volume>135</volume>
<fpage>459</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-017-1793-8</pub-id>
<pub-id pub-id-type="pmid">29196813</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindelin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arganda-Carreras</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Frise</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kaynig</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Longair</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pietzsch</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Preibisch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rueden</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Saalfeld</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tinevez</surname>
<given-names>J-Y</given-names>
</name>
<name>
<surname>White</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Hartenstein</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Eliceiri</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tomancak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cardona</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Fiji: an open-source platform for biological-image analysis</article-title>
<source/>Nat Methods
          <year>2012</year>
<volume>9</volume>
<fpage>676</fpage>
<lpage>682</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id>
<pub-id pub-id-type="pmid">22743772</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sellier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Campanari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Julie Corbier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gaucherot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kolb-Cheynel</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Oulad-Abdelghani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ruffenach</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ciura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kabashi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Charlet-Berguerand</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death</article-title>
<source/>EMBO J
          <year>2016</year>
<volume>35</volume>
<fpage>1276</fpage>
<lpage>1297</lpage>
<pub-id pub-id-type="doi">10.15252/embj.201593350</pub-id>
<pub-id pub-id-type="pmid">27103069</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<mixed-citation publication-type="other">Selvaraj BT, Livesey MR, Zhao C, Gregory JM, James OT, Cleary EM, Chouhan AK, Gane AB, Perkins EM, Dando O, Lillico SG, Lee Y-B, Nishimura AL, Poreci U, Thankamony S, Pray M, Vasistha NA, Magnani D, Borooah S, Burr K, Story D, McCampbell A, Shaw CE, Kind PC, Aitman TJ, Whitelaw CBA, Wilmut I, Smith C, Miles GB, Hardingham GE, Wyllie DJA, Chandran S (2018) C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+−permeable AMPA receptor-mediated excitotoxicity. Nat Commun 9. 10.1038/s41467-017-02729-0</mixed-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sengupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tadić</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Stubendorff</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Keiner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kloss</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Prell</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Witte</surname>
<given-names>OW</given-names>
</name>
<name>
<surname>Grosskreutz</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Interferon-γ receptor 1 and GluR1 upregulated in motor neurons of symptomatic hSOD1G93A mice</article-title>
<source/>Eur J Neurosci
          <year>2019</year>
<volume>49</volume>
<fpage>62</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1111/ejn.14276</pub-id>
<pub-id pub-id-type="pmid">30457201</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Staats</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>W-H</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>S-T</given-names>
</name>
<name>
<surname>Hendricks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Linares</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kisler</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Menendez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Woolwine</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Koutsodendris</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sandor</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Komberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vangoor</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Senthilkumar</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hennes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Seah</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>T-Y</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S-JJ</given-names>
</name>
<name>
<surname>August</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Wisniewski</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hanson-Smith</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Belgard</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coba</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grunseich</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Pasterkamp</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Trotti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zlokovic</surname>
<given-names>BV</given-names>
</name>
<name>
<surname>Ichida</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons</article-title>
<source/>Nat Med
          <year>2018</year>
<volume>24</volume>
<fpage>313</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4490</pub-id>
<pub-id pub-id-type="pmid">29400714</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<mixed-citation publication-type="other">Staats KA, Seah C, Sahimi A, Wang Y, Koutsodendris N, Lin S, Kim D, Chang W-H, Gray KA, Shi Y, Li Y, Chateau M, Vangoor VR, Senthilkumar K, Pasterkamp RJ, Cannon P, Zlokovic BV, Ichida JK (2019) Small molecule inhibition of PIKFYVE kinase rescues gain- and loss-of-function ALS/FTD disease processes. bioRxiv. 10.1101/685800</mixed-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starr</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sattler</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD</article-title>
<source/>Brain Res
          <year>2018</year>
<volume>1693</volume>
<fpage>98</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2018.02.011</pub-id>
<pub-id pub-id-type="pmid">29453960</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swinnen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bento-Abreu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Boeynaems</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bogaert</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nuyts</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Timmers</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scheveneels</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hersmus</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mizielinska</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Isaacs</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lemmens</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Van Damme</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Van Den Bosch</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Robberecht</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism</article-title>
<source/>Acta Neuropathol
          <year>2018</year>
<volume>135</volume>
<fpage>427</fpage>
<lpage>443</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-017-1796-5</pub-id>
<pub-id pub-id-type="pmid">29302778</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tandon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Bannykh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Balch</surname>
<given-names>WE</given-names>
</name>
</person-group>
<article-title>Neurotransmitter release from semi-intact Synaptosomes</article-title>
<source/>Methods
          <year>1998</year>
<volume>16</volume>
<fpage>198</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1006/meth.1998.0667</pub-id>
<pub-id pub-id-type="pmid">9790866</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Decoding ALS: from genes to mechanism</article-title>
<source/>Nature
          <year>2016</year>
<volume>539</volume>
<fpage>197</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1038/nature20413</pub-id>
<pub-id pub-id-type="pmid">27830784</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Therrien</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Dion</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e83450</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0083450</pub-id>
<pub-id pub-id-type="pmid">24349511</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troakes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Maekawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wijesekera</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogelj</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Siklós</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Newhouse</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vance</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hortobágyi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shatunov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Chalabi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leigh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>King</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Sarraj</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>An MND/ALS phenotype associated with <italic>C9orf72</italic> repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline: p62 proteinopathy</article-title>
<source/>Neuropathology
          <year>2012</year>
<volume>32</volume>
<fpage>505</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1789.2011.01286.x</pub-id>
<pub-id pub-id-type="pmid">22181065</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ugolino</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Conchina</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nirujogi</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Hamacher-Brady</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Loss of C9orf72 enhances Autophagic activity via deregulated mTOR and TFEB signaling</article-title>
<source/>PLoS Genet
          <year>2016</year>
<volume>12</volume>
<fpage>e1006443</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1006443</pub-id>
<pub-id pub-id-type="pmid">27875531</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinade</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schlief</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Reese</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Tao-Cheng</surname>
<given-names>J-H</given-names>
</name>
<name>
<surname>Dosemeci</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Affinity purification of PSD-95-containing postsynaptic complexes: affinity-purified postsynaptic densities</article-title>
<source/>J Neurochem
          <year>2003</year>
<volume>87</volume>
<fpage>1255</fpage>
<lpage>1261</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.02091.x</pub-id>
<pub-id pub-id-type="pmid">14622105</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waite</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bäumer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>East</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Neal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Ansorge</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion</article-title>
<source/>Neurobiol Aaging
          <year>2014</year>
<volume>35</volume>
<fpage>1779.e5</fpage>
<lpage>1779.e13</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.01.016</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>JCH</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Giannandrea</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Galea</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Riseley</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>SEM</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Gregg</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Bromhead</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Wargowski</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>James</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Churchyard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Phelan</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Gillies</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Salce</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Stanford</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>APL</given-names>
</name>
<name>
<surname>Mignogna</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Hayflick</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Leventer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Delatycki</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Mellick</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Kalscheuer</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>D’Adamo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bahlo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Amor</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Lockhart</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-Synuclein pathology</article-title>
<source/>Am J Hum Genet
          <year>2014</year>
<volume>95</volume>
<fpage>729</fpage>
<lpage>735</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.10.015</pub-id>
<pub-id pub-id-type="pmid">25434005</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>van Blitterswijk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McGoldrick</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Yunusova</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Knock</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McKeever</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Keith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Petrescu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tartaglia</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Graff-Radford</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Boylan</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Mackenzie</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Jump from pre-mutation to pathologic expansion in C9orf72</article-title>
<source/>Am J Hum Genet
          <year>2015</year>
<volume>96</volume>
<fpage>962</fpage>
<lpage>970</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2015.04.016</pub-id>
<pub-id pub-id-type="pmid">26004200</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grinberg</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bilbao</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ghani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hernández</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morón</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Marras</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bruni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Colao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Maletta</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Puccio</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rainero</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pinessi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Galimberti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Moorby</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stockton</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Masellis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Hazrati</surname>
<given-names>L-N</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>van Haersma de With</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fornazzari</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Villagra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rojas-Garcia</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Clarimón</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mayeux</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>St George-Hyslop</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Investigation of C9orf72 in 4 neurodegenerative disorders</article-title>
<source/>Arch Neurol
          <year>2012</year>
<volume>69</volume>
<fpage>1583</fpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2012.2016</pub-id>
<pub-id pub-id-type="pmid">22964832</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>MacNair</surname>
<given-names>L</given-names>
</name>
<name>
<surname>McGoldrick</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McKeever</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Keith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis: C9orf72 isoforms in ALS</article-title>
<source/>Ann Neurol
          <year>2015</year>
<volume>78</volume>
<fpage>568</fpage>
<lpage>583</lpage>
<pub-id pub-id-type="doi">10.1002/ana.24469</pub-id>
<pub-id pub-id-type="pmid">26174152</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>MacNair</surname>
<given-names>L</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McGoldrick</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McKeever</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Soleimani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Keith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>C9orf72 isoforms in amyotrophic lateral sclerosis and Frontotemporal lobar degeneration</article-title>
<source/>Brain Res
          <year>2016</year>
<volume>1647</volume>
<fpage>43</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2016.04.062</pub-id>
<pub-id pub-id-type="pmid">27134035</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Poidevin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hales</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Gearing</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wingo</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration</article-title>
<source/>Proc Natl Acad Sci
          <year>2013</year>
<volume>110</volume>
<fpage>7778</fpage>
<lpage>7783</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1219643110</pub-id>
<pub-id pub-id-type="pmid">23553836</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Swaminathan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Herrlinger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shiekhattar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J-F</given-names>
</name>
</person-group>
<article-title>A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy</article-title>
<source/>Sci Adv
          <year>2016</year>
<volume>2</volume>
<fpage>e1601167</fpage>
<pub-id pub-id-type="doi">10.1126/sciadv.1601167</pub-id>
<pub-id pub-id-type="pmid">27617292</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshimura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gerondopoulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Linford</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rigden</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors</article-title>
<source/>J Cell Biol
          <year>2010</year>
<volume>191</volume>
<fpage>367</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.201008051</pub-id>
<pub-id pub-id-type="pmid">20937701</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<mixed-citation publication-type="other">Zhang D, Iyer LM, He F, Aravind L (2012) Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front Genet 3. 10.3389/fgene.2012.00283</mixed-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Burberry</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J-Y</given-names>
</name>
<name>
<surname>Sandoe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Udeshi</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Svinkina</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mordes</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Charlton</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q-Z</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Eggan</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis</article-title>
<source/>Genes Dev
          <year>2018</year>
<volume>32</volume>
<fpage>929</fpage>
<lpage>943</lpage>
<pub-id pub-id-type="doi">10.1101/gad.313932.118</pub-id>
<pub-id pub-id-type="pmid">29950492</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>